Prof. Jurgen Rohr from University of Kentucky visited TIB at the invitation of Prof. Tao Liu on Octorber 17, 2014.
Prof. Jibin Sun, the Deputy Director-General of TIB, on behalf of CAS, issued the certificate of CAS Visiting Professorship to Prof. Jurgen Rohr. Thereafter, Prof. Jurgen Rohr gave a lecture entitled “Evolution of Natural Products for Cancer Chemotherapy”. In the lecture, he presented the investigations of the complex biosyntheses and further modification of anticancer drugs (mithramycin, landomycin, gilvocarcin) undertaken by his research group through pathway reconstitution, systematic studies and recombination of its enzyme components. Researchers from TIB discussed deeply about certain issues with Prof. Jurgen Rohr during and after the lecture.
Introduction to Prof. Jurgen Rohr: Prof. Jurgen Rohr now is the full Professor at the College of Pharmacy of the University of Kentucky in 2002, and is the Director of the Division of Drug Discovery since 2007. He is awarded the CAS Visiting Professorships for Senior International Scientists in 2014. His research interests span isolation and structure elucidation of natural products, biosynthetic studies of microbial natural products, combinatorial biosynthesis, enzymology and chemo-enzymatic derivatization, with focus on polyketide anticancer drugs.
Prof. Jibin Sunissued the certificate of CAS Visiting Professorship to Prof. Jurgen Rohr